###begin article-title 0
Type I interferon drives tumor necrosis factor-induced lethal shock
###end article-title 0
###begin p 1
L. Huys and F. Van Hauwermeiren contributed equally to this paper.
###end p 1
###begin p 2
###xml 577 580 570 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 780 783 773 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 978 981 971 974 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 150 156 <span type="species:ncbi:9606">humans</span>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">Mice</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 712 716 <span type="species:ncbi:10090">mice</span>
###xml 784 788 <span type="species:ncbi:10090">mice</span>
###xml 856 860 <span type="species:ncbi:10090">mice</span>
###xml 982 986 <span type="species:ncbi:10090">mice</span>
###xml 1199 1203 <span type="species:ncbi:10090">mice</span>
Tumor necrosis factor (TNF) is reputed to have very powerful antitumor effects, but it is also a strong proinflammatory cytokine. Injection of TNF in humans and mice leads to a systemic inflammatory response syndrome with major effects on liver and bowels. TNF is also a central mediator in several inflammatory diseases. We report that type I interferons (IFNs) are essential mediators of the lethal response to TNF. Mice deficient in the IFN-alpha receptor 1 (IFNAR-1) or in IFN-beta are remarkably resistant to TNF-induced hypothermia and death. After TNF injection, IFNAR-1-/- mice produced less IL-6, had less bowel damage, and had less apoptosis of enterocytes and hepatocytes compared with wild-type (WT) mice. Extensive gene expression analysis in livers of WT and IFNAR-1-/- mice revealed a large deficiency in the response to TNF in the knockout mice, especially of IFN-stimulated response element-dependent genes, many of which encode chemokines. In livers of IFNAR-1-/- mice, fewer infiltrating white blood cells (WBCs) were detected by immunohistochemistry. Deficiency of type I IFN signaling provided sufficient protection for potentially safer therapeutic use of TNF in tumor-bearing mice. Our data illustrate that type I IFNs act as essential mediators in TNF-induced lethal inflammatory shock, possibly by enhancing cell death and inducing chemokines and WBC infiltration in tissues.
###end p 2
###begin p 3
###xml 182 205 178 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Brouckaert et al., 1986</xref>
###xml 336 358 332 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Eggermont et al., 2004</xref>
###xml 416 444 412 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Aggarwal and Natarajan, 1996</xref>
###xml 619 639 615 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Kollias et al., 1999</xref>
###xml 784 803 780 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Tracey et al., 1986</xref>
###xml 805 826 801 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Vassalli et al., 1992</xref>
###xml 916 938 912 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Everaerdt et al., 1994</xref>
###xml 945 965 941 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Cauwels et al., 2000</xref>
###xml 995 1017 991 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Takahashi et al., 2008</xref>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 211 219 <span type="species:ncbi:9606">patients</span>
The cytokine TNF, especially in combination with IFN-gamma, has a very strong antitumor effect. In mice, for example, established tumors completely regress during 10 d of treatment (Brouckaert et al., 1986). In patients, treatment of tumors with TNF leads to remarkable results, as in the treatment of melanoma metastasis in the limbs (Eggermont et al., 2004). However, TNF is a very strong inducer of inflammation (Aggarwal and Natarajan, 1996). After TNF binds to its major receptor TNFR1 (p55), it activates a broad range of transcription factors, leading to induction of cytokines, enzymes, and adhesion molecules (Kollias et al., 1999). Thus, injection of TNF leads to a systemic inflammatory response syndrome (SIRS) characterized by hypotension, hepatitis, and bowel necrosis (Tracey et al., 1986; Vassalli et al., 1992). Several molecules have been proven to mediate the acutely lethal effects of TNF: IL-1 (Everaerdt et al., 1994), NO (Cauwels et al., 2000), and, more recently, IL-17 (Takahashi et al., 2008). Because of these strong proinflammatory effects, treatment with TNF is restricted to loco-regional settings.
###end p 3
###begin p 4
###xml 102 118 102 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Ank et al., 2006</xref>
###xml 343 359 336 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Uz&#233; et al., 2007</xref>
###xml 530 555 523 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Karaghiosoff et al., 2003</xref>
###xml 557 580 550 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Mahieu and Libert, 2007</xref>
Three types of IFNs have been identified: type I, type II, and the recently discovered type III IFNs (Ank et al., 2006). Type I IFNs form a group of almost 20 members, of which IFN-beta is one of the most important. They all signal through a heterodimeric receptor complex consisting of an IFN-alpha receptor 1 (IFNAR-1) and an IFNAR-2 chain (Uze et al., 2007). Also, type I IFNs have antiviral, apoptotic, and antitumor activities, and they have been shown to mediate the acute inflammatory shock that occurs during endotoxemia (Karaghiosoff et al., 2003; Mahieu and Libert, 2007).
###end p 4
###begin p 5
###xml 193 214 193 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Yarilina et al., 2008</xref>
It was recently shown that TNF stimulates the expression of type I IFNs through IRF-1 in macrophages and, via IFNAR-1, the expression of IFN-stimulated response element (ISRE)-dependent genes (Yarilina et al., 2008). We therefore wondered whether type I IFNs play a role in the TNF-induced acutely lethal SIRS. Our data clearly support the idea that type I IFNs are strong mediators of the in vivo TNF effects and that their inhibition could lead to safer antitumor therapy based on TNF.
###end p 5
###begin title 6
RESULTS AND DISCUSSION
###end title 6
###begin title 7
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 28 31 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
IFNAR-1-/- mice and IFN-beta-/- mice are protected against TNF-induced lethal SIRS
###end title 7
###begin p 8
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 69 72 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 154 157 151 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 234 237 227 230 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">100</sub>
###xml 368 371 361 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 399 407 392 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 436 439 429 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 543 551 536 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 673 676 662 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 879 898 868 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Libert et al., 1994</xref>
###xml 936 944 925 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 1006 1009 995 998 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1153 1156 1142 1145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1329 1332 1318 1321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1411 1414 1400 1403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1568 1571 1554 1557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1692 1707 1678 1693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1, D and E</xref>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 219 224 <span type="species:ncbi:10090">mouse</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
###xml 580 584 <span type="species:ncbi:10090">mice</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 1010 1014 <span type="species:ncbi:10090">mice</span>
###xml 1157 1161 <span type="species:ncbi:10090">mice</span>
###xml 1333 1337 <span type="species:ncbi:10090">mice</span>
###xml 1415 1419 <span type="species:ncbi:10090">mice</span>
###xml 1572 1576 <span type="species:ncbi:10090">mice</span>
###xml 1591 1595 <span type="species:ncbi:10090">mice</span>
We studied the role of type I IFNs by using IFNAR-1-/- mice, IFN-beta-/- mice, and WT mice. All mice had a matching genetic background of C57BL/6. IFNAR-1-/- and WT mice were injected i.p. with 30 microg of recombinant mouse TNF (2xLD100 for WT mice) and mortality was recorded during 72 h, after which no further deaths occurred. All WT mice died, whereas all IFNAR-1-/- mice survived (P < 0.0001; Fig. 1 A). Moreover, although IFNAR-1-/- mice displayed a mild and transient hypothermia, WT mice suffered pronounced hypothermia before dying (Fig. 1 B). In another experiment, 24 mice per genotype were injected i.p. with 30 microg TNF, and groups of six WT and six IFNAR-1-/- mice were bled at different times to study the induction profile of IL-6. Although this cytokine is functionally inert in this TNF model, its induction profile illustrates the extent of gene induction (Libert et al., 1994) and inflammation. As can be seen in Fig. 1 C, basal serum levels of IL-6 were comparable in WT and IFNAR-1-/- mice, but 2, 6, and 10 h after TNF challenge, the increase in IL-6 serum concentrations was significantly more pronounced in WT than in IFNAR-1-/- mice. It is notable that the difference from the WT developed relatively quickly. Furthermore, serum concentrations of IL-12p40 and IL-12p70 were also much lower in IFNAR-1-/- mice 6 h after challenge (unpublished data). Because we found that our IFNAR-1-/- mice displayed a mild reduction in the numbers of NK and NKT cells in liver but not in spleen (unpublished data), we also tested the response of IFN-beta-/- mice to TNF. These mice were also significantly resistant to the lethal effects of TNF (P = 0.0027) and to hypothermia (Fig. 1, D and E).
###end p 8
###begin p 9
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 28 31 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 72 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR-1<sup>&#8722;/&#8722;</sup> mice and IFN-&#946;<sup>&#8722;/&#8722;</sup> mice are resistant to TNF-induced shock.</bold>
###xml 112 113 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 131 134 124 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 136 137 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 336 339 329 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 353 354 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 524 525 509 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 544 547 526 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 549 550 531 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 557 561 <span type="species:ncbi:10090">mice</span>
IFNAR-1-/- mice and IFN-beta-/- mice are resistant to TNF-induced shock. 30 microg TNF was injected i.p. in WT (n = 14) and IFNAR-1-/- (n = 14) mice. (A) Mortality was monitored for 72 h (no further deaths occurred). (B) Body temperatures were measured regularly and plotted in function of time. (C) New groups of WT (black) and IFNAR-1-/- (gray) mice (n = 44 in total) were injected with 30 microg TNF i.p. and bled for IL-6 determination. IL-6 values are expressed on a log scale. 17.5 microg TNF was injected i.p. in WT (n = 12) and IFN-beta-/- (n = 12) mice. (D) Mortality was monitored for 72 h (no further deaths occurred). (E) Body temperatures were measured regularly and plotted as a function of time. Experiments in A-C were performed three times; D and E were performed twice. Error bars represent SD of the means. *, 0.01 </= P </= 0.05; **, 0.001 </= P </= 0.01; ***, P </= 0.001.
###end p 9
###begin p 10
###xml 215 218 215 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 369 377 369 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 471 492 471 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Halpern et al. (2003)</xref>
###xml 548 551 548 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 636 644 636 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
Sections of the small intestines (ileum) were made 1 and 6 h after challenge and stained with hematoxylin/eosin. As early as 1 h after challenge, the detrimental effect of TNF was much less pronounced in the IFNAR-1-/- mice than in WT mice. We observed less shrinkage and erosion of villi, less mucus formation, fewer apoptotic nuclei, and milder loss of Goblet cells (Fig. 2 A). The degree of tissue damage in these sections was quantified using the method described by Halpern et al. (2003). Significantly less damage was induced by TNF in IFNAR1-/- than in WT mice 1 and 6 h after challenge (P = 0.0255 and P = 0.0046, respectively; Fig. 2 B).
###end p 10
###begin p 11
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bowel damage after TNF injection in WT mice and IFNAR-1<sup>&#8722;/&#8722;</sup> mice.</bold>
###xml 76 79 76 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 189 190 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 208 211 204 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 218 219 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 256 257 252 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 269 270 265 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 286 287 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 494 497 490 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 751 754 743 746 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
###xml 468 472 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 732 736 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
Bowel damage after TNF injection in WT mice and IFNAR-1-/- mice. (A) IFNAR-1-/- mice are protected against TNF-induced bowel tissue destruction. 30 microg TNF was injected i.p. in WT mice (n = 18) and IFNAR-1-/- mice (n = 18), and jejunum was sampled 0 h (n = 6), 1 h (n = 6), and 6 h (n = 6) later. Standard hematoxylin/eosin staining of control samples (left), 1 h (middle), and 6 h (right) after TNF injection showed more extensive tissue damage in the bowel of WT mice (top) than in IFNAR-1-/- mice (bottom). Bars, 50 microm. The experiment was performed twice. (B) Neutral observers quantified the degree of bowel toxicity in sections from an independent experiment. The experiment was analogous to the one in A but used 19 WT mice and 18 IFNAR-1-/- mice. Error bars represent SD of the means. *, 0.01 </= P </= 0.05; **, 0.001 </= P </= 0.01.
###end p 11
###begin p 12
###xml 83 102 83 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Piguet et al., 1998</xref>
###xml 267 283 267 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Qiu et al., 2008</xref>
###xml 381 401 381 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Lechner et al., 2008</xref>
###xml 580 598 580 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Ding and Yin, 2004</xref>
###xml 793 796 793 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1061 1069 1057 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 1240 1243 1236 1239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1405 1413 1401 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 797 801 <span type="species:ncbi:10090">mice</span>
###xml 825 829 <span type="species:ncbi:10090">Mice</span>
###xml 1244 1248 <span type="species:ncbi:10090">mice</span>
###xml 1260 1264 <span type="species:ncbi:10090">mice</span>
###xml 1399 1403 <span type="species:ncbi:10090">mice</span>
Acute cell death (apoptosis) of enterocytes after TNF injection has been reported (Piguet et al., 1998), and our data indicate that this TNF effect is enhanced by type I IFNs. The apoptosis-enhancing activity of type I IFN was recently shown for macrophages as well (Qiu et al., 2008). Furthermore, type I IFNs have been shown to exert apoptotic effects on renal epithelial cells (Lechner et al., 2008). TNF not only induces apoptosis of enterocytes, it also induces multiple mechanisms through the death receptor pathway to initiate hepatocyte apoptosis leading to liver injury (Ding and Yin, 2004). Liver injury has been identified as a major dose-limiting toxicity of TNF. We therefore compared the degree of acute enterocyte apoptosis and liver damage after TNF injection in WT and IFNAR-1-/- mice by several techniques. Mice were injected with 30 microg TNF, and the degree of apoptosis was estimated in bowels and livers 1 and 6 h after injection by measuring the extent of DNA fragmentation, caspase 3/caspase 7 activity, and TUNEL staining. As shown in Fig. 3 A, the extent of DNA fragmentation induced by TNF was very high in intestines 1 h after challenge and in liver 6 h after challenge, but it was significantly less in IFNAR-1-/- mice than in WT mice (P = 0.03986 and P = 0.0313, respectively). A similar pattern was observed when studying caspase 3/caspase 7 activity in TNF-injected mice (Fig. 3 B) or when staining sections for TUNEL activity (not depicted).
###end p 12
###begin p 13
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF induces less apoptosis in IFNAR-1<sup>&#8722;/&#8722;</sup> mice than in WT mice.</bold>
###xml 117 120 113 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 167 168 163 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 182 183 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 201 202 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
TNF induces less apoptosis in IFNAR-1-/- mice than in WT mice. 30 microg TNF was injected i.p. in WT mice and IFNAR-1-/- mice, and jejunum and liver were sampled 0 h (n = 7-8), 1 h (n = 7-8), and 6 h (n = 8) later. (A) The degree of DNA fragmentation was measured and expressed as an enrichment factor compared with the 0-h values. (B) The sum of the activities of caspase 3 and caspase 7 was determined and expressed in relative luminescence units (RLU). The entire experiment was performed twice. Error bars represent SD of the means. *, 0.01 </= P </= 0.05; **, 0.001 </= P </= 0.01.
###end p 13
###begin p 14
###xml 359 378 359 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Tracey et al., 1986</xref>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
We conclude that abolition of type I IFN signaling protects mice against the acute inflammatory and toxic effects of TNF. The protective effect is initiated early and is reflected in the lower degree of hypothermia and lower level of circulating IL-6, as well as in reduced enterocyte and liver apoptosis, which are the major dose-limiting toxicities of TNF (Tracey et al., 1986).
###end p 14
###begin title 15
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Reduced expression of genes after TNF injection in IFNAR-1-/- mice
###end title 15
###begin p 16
###xml 101 122 98 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Yaralina et al., 2008</xref>
###xml 188 209 185 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Wielockx et al., 2001</xref>
###xml 381 384 375 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 391 399 385 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 484 487 475 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 536 555 527 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Fenner et al., 2006</xref>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 765 769 <span type="species:ncbi:10090">mice</span>
Very moderate induction of the major type I IFN (IFN-beta) by TNF was recently shown in macrophages (Yaralina et al., 2008). Because the liver has been reported as a major target for TNF (Wielockx et al., 2001), we studied the levels of IFN-beta messenger RNA in livers by quantitative PCR and found a sharp but transient induction in WT mice and a slow gradual increase in IFNAR-1-/- mice (Fig. 4 A). The late appearance of IFN-beta at the RNA level after injection of TNF in IFNAR-1-/- mice might be, as has been proposed previously (Fenner et al., 2006), the result of weaker induction of inhibitors of the Jak-Stat pathway, such as SOCS molecules, by IFN-beta. It should be noted that no IFN activity could be measured in serum or liver extract of TNF-injected mice by IFN-beta-specific ELISA or by a sensitive bioassay based on the antiviral activity of IFN.
###end p 16
###begin p 17
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 81 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF-induced gene expression in liver is lower in IFNAR-1<sup>&#8722;/&#8722;</sup> mice than in WT mice.</bold>
###xml 86 87 86 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 111 114 111 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 116 117 116 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
TNF-induced gene expression in liver is lower in IFNAR-1-/- mice than in WT mice. WT (n = 4; black) and IFNAR-1-/- (n = 4; gray) mice were injected with 30 microg TNF i.p. and RNA was isolated 0, 1, 2, 6, and 10 h after injection. Quantitative PCR was used to measure gene-specific RNA levels of a set of early genes encoding IFN-beta (A), IRF-1 (B), iNOS (C), IL-1beta (D), and c-FLIP (E), as well as ISRE genes encoding CXCL9 (F), CXCL10 (G), CXCL11 (H), IFIT2 (I), STAT1 (J), and IRF-7 (K). The experiment was performed twice. Error bars represent SD of the means. *, 0.01 </= P </= 0.05; **, 0.001 </= P </= 0.01; ***, P </= 0.001.
###end p 17
###begin p 18
###xml 293 296 289 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 416 424 412 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 614 617 603 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 660 671 649 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4, C&#8211;E</xref>
###xml 966 985 944 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Hooghe et al., 2008</xref>
###xml 1078 1094 1056 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Liu et al., 2004</xref>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
To study the effects of IFNAR-1 deletion on TNF-induced gene expression in vivo, we measured the expression of several genes in the liver and spleen 0, 2, 6, and 10 h after injection of 30 microg TNF. In both the liver and spleen, the expression of all studied genes was compromised in IFNAR-1-/- mice. When we examined the induction of early genes by TNF, the large difference in induction of IRF-1 was remarkable (Fig. 4 B). The induction of other genes that depend on NF-kappaB, such as those coding for inducible nitric oxide synthase (iNOS), IL-1beta, and c-Flip, was also substantially compromised in IFNAR-1-/- mice, especially at the early time point (Fig. 4, C-E). This can be explained, at least for the iNOS and IL-1beta genes, by their coregulation by NF-kappaB and IRF factors and also in the promoter of the c-Flip-encoding gene because NF-kappaB, as well as IRF-responsive elements, was found by using the bioinformatics program Contra (not depicted; Hooghe et al., 2008). The lower level of serum IL-12 can also be explained by this reduced expression of IRF-1 (Liu et al., 2004).
###end p 18
###begin p 19
###xml 93 96 93 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 336 347 336 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4, F&#8211;K</xref>
###xml 585 603 585 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Maher et al., 2007</xref>
###xml 683 699 683 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Der et al., 1998</xref>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
When comparing the induction of later Jak-Stat-dependent genes, the expression in the IFNAR-1-/- mice was again found to be greatly reduced. The genes encoding CXCL9, CXCL10, CXCL11, IFIT2, STAT1, and IRF-7 were induced by TNF in the liver of WT mice but to a much smaller extent (or not at all) in the absence of the IFNAR-1 receptor (Fig. 4, F-K). These genes belong to the group of ISRE genes, the promoters of which are controlled by the transcription complex ISGF3. This complex consists of STAT-1-STAT-2-IRF-9 heterotrimers and is formed after stimulation of the IFNAR receptor (Maher et al., 2007). Most ISRE genes have immune modulatory, antiviral, or chemotactic functions (Der et al., 1998). Deficient induction of a whole set of chemokines, such as CXCL9, CXCL10, CXCL11, and IFIT2, should have profound effects on the chemotaxis of white blood cells (WBCs) in vivo.
###end p 19
###begin title 20
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Reduced infiltration of WBC in IFNAR-1-/- mice
###end title 20
###begin p 21
###xml 125 128 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 728 734 724 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5</xref>
###xml 784 787 780 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 909 912 905 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1008 1011 1004 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 788 792 <span type="species:ncbi:10090">mice</span>
###xml 913 917 <span type="species:ncbi:10090">mice</span>
###xml 1012 1016 <span type="species:ncbi:10090">mice</span>
###xml 1075 1079 <span type="species:ncbi:10090">mice</span>
Because the induction of several chemokines upon TNF injection seemed much weaker (or altogether absent) in livers of IFNAR-1-/- mice compared with WT mice, we investigated whether infiltration of tissues by WBCs was reduced. Indeed, stimulation of the IFNAR-1 receptor in WT mice is expected to produce chemokines, which attract WBC from the blood stream into the tissue to cause further damage. Therefore, we injected mice i.p. with 30 microg TNF and sampled livers 6 h later. We also took samples from untreated mice. Tissue sections were stained for several WBC markers, namely the general WBC marker CD45, the T cell marker CD3, the marker for polymorphonuclear cells and monocytes MPO, and F4/80, a marker of macrophages (Fig. 5). The numbers of positive cells in WT and IFNAR-1-/- mice were compared. In the liver, we found that the numbers of WBC in the parenchyma were significantly lower in IFNAR1-1-/- mice whether they were CD3, CD45, MPO, or F4/80 positive. It is noteworthy that WBCs in IFNAR-1-/- mice seemed to accumulate in veins and arteries, whereas in WT mice they crossed the endothelial barrier into the parenchyma. Because CXCL9, CXCL10, and CXCL11 bind to the rather generally expressed receptor CxCR3 on WBCs, the reduced infiltration of CD3-, CD45-, MPO-, and F4/80-positive cells can be explained.
###end p 21
###begin p 22
###xml 42 45 42 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Reduced tissue migration of WBC in IFNAR-1<sup>&#8722;/&#8722;</sup> mice after injection with TNF.</bold>
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 99 102 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 104 105 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
Reduced tissue migration of WBC in IFNAR-1-/- mice after injection with TNF. WT (n = 6) and IFNAR-1-/- (n = 6) mice were injected i.p. with 30 microg TNF and livers were isolated 0 or 6 h later. Sections were cut and stained with CD45, CD3, MPO, and F4/80. Five representative fields were selected in all samples and the mean number of positive cells in five fields at 40x was counted by a neutral observer. Bars, 50 microm. IHC was performed three times. Error bars represent SD of the means. *, 0.01 </= P </= 0.05; **, 0.001 </= P </= 0.01; ***, P </= 0.001.
###end p 22
###begin title 23
###xml 53 56 49 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Safer antitumor therapy with TNF/IFN-gamma in IFNAR-1-/- mice
###end title 23
###begin p 24
###xml 270 273 270 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 290 291 290 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 363 366 363 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 415 423 415 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 A</xref>
###xml 528 543 528 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Li et al., 2008</xref>
###xml 768 769 760 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 787 790 779 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 797 798 789 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 805 813 797 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 B</xref>
###xml 859 862 851 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 905 913 897 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 C</xref>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 409 413 <span type="species:ncbi:10090">mice</span>
###xml 550 554 <span type="species:ncbi:10090">mice</span>
###xml 676 681 <span type="species:ncbi:10090">mouse</span>
###xml 791 795 <span type="species:ncbi:10090">mice</span>
###xml 826 830 <span type="species:ncbi:10090">mice</span>
###xml 863 867 <span type="species:ncbi:10090">mice</span>
The protection provided by knockout of IFNAR-1 against acute lethal SIRS induced by a bolus injection of TNF raises hopes that it might be protective in an antitumor model as well. We studied this possibility in a standard tumor model. We inoculated 19 WT and 20 IFNAR-1-/- mice with 6 x 105 B16BL6 melanoma cells in the right thigh. 10 d later, tumors in IFNAR-1-/- mice had grown slightly larger than in WT mice (Fig. 6 A). This confirms earlier findings and illustrates that type I IFNs have some antiproliferative activity (Li et al., 2008). The mice were then divided into four groups and injected near the lesions with PBS or with 15 microg TNF + 5,000 IU IFN-gamma per mouse per day. Daily measurement of tumor index showed that tumors regressed equally in WT (n = 10) and IFNAR-1-/- mice (n = 10; Fig. 6 B). All 10 WT mice and only 2 out of 10 IFNAR-1-/- mice died from the treatment (P = 0.0003; Fig. 6 C). This illustrates that type I IFNs also mediate much of the toxicity associated with the anticancer activity of TNF/IFN-gamma.
###end p 24
###begin p 25
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 76 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Protection of tumor-bearing IFNAR-1<sup>&#8722;/&#8722;</sup> mice against TNF/IFN-&#947; lethality.</bold>
###xml 81 82 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 129 132 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 134 135 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 366 369 323 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 426 429 379 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 594 595 547 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 613 616 566 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 618 619 571 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 461 466 <span type="species:ncbi:10090">mouse</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
Protection of tumor-bearing IFNAR-1-/- mice against TNF/IFN-gamma lethality. WT (n = 19; blacksquare, square, filled) and IFNAR-1-/- (n = 20; black triangle) mice were inoculated with B16BL6 melanoma cells. 10 d later, tumors were measured, TSI was calculated (A), and treatment was started. Treatment was daily for 10 d with PBS (black lines) in 9 WT and 10 IFNAR-1-/- mice or with TNF/IFN-gamma (red) in 10 WT and 10 IFNAR-1-/- mice. Tumor regression (B) and mouse survival (C) were recorded until the end of the treatment (no further deaths occurred). The difference in survival between WT (n = 10) and IFNAR-1-/- (n = 10) mice was highly significant. The experiment was performed twice. Error bars represent SD of the means. *, 0.01 </= P </= 0.05; ***, P </= 0.001.
###end p 25
###begin p 26
###xml 123 141 123 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Maher et al., 2007</xref>
###xml 631 656 628 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Karaghiosoff et al., 2003</xref>
###xml 658 681 655 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Mahieu and Libert, 2007</xref>
###xml 941 963 938 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Yarilina et al. (2008)</xref>
###xml 1267 1270 1261 1264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 5 13 <span type="species:ncbi:9606">patients</span>
###xml 110 113 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 118 121 <span type="species:ncbi:11103?0.9633797444211329|species:ncbi:11096?0.008773602899103566">HCV</span>
###xml 159 167 <span type="species:ncbi:9606">patients</span>
###xml 550 554 <span type="species:ncbi:10090">mice</span>
###xml 1108 1116 <span type="species:ncbi:9606">patients</span>
###xml 1271 1275 <span type="species:ncbi:10090">mice</span>
Many patients have been treated with type I IFNs for cancer, multiple sclerosis, and viral infections such as HBV and HCV (Maher et al., 2007). Although these patients suffer from severe side effects of the treatment, no serious accidents have been reported. However, although type I IFNs have been shown to possess some antiinflammatory activities, especially in the central nervous system, several authors have shown that they should be considered as important mediators in acute inflammatory conditions. Absence of IFN-beta or IFNAR-1 in knockout mice leads to complete protection against LPS-induced lethal inflammatory shock (Karaghiosoff et al., 2003; Mahieu and Libert, 2007). In our study, we found that the presence or absence of type I IFN signaling also has a large impact on the outcome of TNF-induced inflammation. We expect that type I IFNs are also involved in other TNF-induced or TNF-mediated pathologies such as arthritis. Yarilina et al. (2008) found that TNF in macrophages induces a typical type I IFN program through IRF-1 and that IFN-beta was elevated in synovial fluids of arthritic patients. Therefore, therapeutic inhibition of type I IFNs is conceivable. The endogenous type I IFNs, however, are crucial for antiviral defences, and IFNAR-1-/- mice are hypersensitive to many viral infections. Hence, although therapeutic inhibition of type I IFNs in inflammatory conditions seems logical, it is difficult to achieve in practice.
###end p 26
###begin p 27
###xml 756 775 756 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">M&#252;ller et al., 1994</xref>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
In conclusion, deficiency of type I IFNs in vivo leads to considerable protection against the deleterious effects of TNF. Two mechanisms might be involved in this protection. Type I IFNs seem to enhance TNF-induced apoptosis in enterocytes and hepatocytes. In contrast, deficient induction of chemokine genes is observed and is reflected in reduced infiltration of inflammatory cells in mice deficient in type I IFN receptor. Therapeutic inhibition of this family of IFNs should be evaluated for treatment of disorders in which TNF is implicated or for increasing the therapeutic index of TNF in cancer therapy. The safety of therapeutic inhibition with anti-type I IFN agents should be evaluated because these IFNs possess essential antiviral activities (Muller et al., 1994).
###end p 27
###begin title 28
MATERIALS AND METHODS
###end title 28
###begin title 29

###end title 29
###begin title 30
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 30
###begin p 31
###xml 95 98 95 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 137 140 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
C57BL/6J WT mice were purchased from Charles River Laboratories. IFNAR-1 knockout mice (IFNAR-1-/-) and IFN-beta knockout mice (IFN-beta -/-), both with a C57BL/6J genetic background, were provided by D. Bonaparte (Gulbenkian Institute of Science, Oeiras, Portugal) and S. Weiss, respectively. The mice were kept in individually ventilated cages in a conventional animal house and were used at the age of 8-12 wk. Animal studies were approved by the ethics committee of Ghent University.
###end p 31
###begin title 32
Agents.
###end title 32
###begin p 33
###xml 53 69 49 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 172 173 164 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 193 194 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 12 17 <span type="species:ncbi:10090">mouse</span>
###xml 53 69 <span type="species:ncbi:562">Escherichia coli</span>
Recombinant mouse TNF and IFN-gamma were produced in Escherichia coli and purified to homogeneity in our laboratories. TNF and IFN-gamma had specific activities of 1.2 x 108 IU/mg and 1.16 x 107 IU/mg, respectively, with no detectable endotoxin contamination.
###end p 33
###begin title 34
Injections, monitoring, and sampling.
###end title 34
###begin p 35
###xml 349 350 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
TNF was diluted in endotoxin-free PBS and injected i.p. in a volume of 0.2 ml. Mortality was scored for 72 h. Serum and tissue samples were collected 0, 1, 2, 6, and 10 h after injection. Blood was withdrawn by cardiac puncture and allowed to clot overnight at 4degreesC. The clot was removed, and serum was collected after centrifugation at 20,000 g for 10 min and stored at -20degreesC. Tissue samples were fixed briefly and embedded in paraffin by a standard protocol (Tissue-Tek VIP; Sakura). RNA samples were isolated by using RNeasy (QIAGEN).
###end p 35
###begin title 36
Tumor cell culture and inoculation.
###end title 36
###begin p 37
###xml 87 88 87 88 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 192 193 192 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 58 62 <span type="species:ncbi:9913">calf</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
B16BL6 cells were cultured in DME supplemented with fetal calf serum, antibiotics, and l-glutamine. Cells were harvested, washed three times in LPS-free PBS, and brought to a density of 6 x 106/ml. From this cell suspension, 100 microl was injected s.c. into the right hind limbs of the mice.
###end p 37
###begin title 38
Tumor size index (TSI) and body temperature.
###end title 38
###begin p 39
The smaller and larger diameters of the tumors were measured with an electronic caliper, and TSI was calculated by multiplying these two values. Rectal body temperature was measured with an electronic thermometer (model 2001; Comark).
###end p 39
###begin title 40
Determination of IL-6 and IFN-beta.
###end title 40
###begin p 41
###xml 54 76 54 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Van Snick et al., 1986</xref>
IL-6 was determined in serum as previously described (Van Snick et al., 1986). Levels of IFN-beta in serum and in liver extracts were determined by an ELISA system (PBL Biomedical Laboratories) according to the manufacturer's instructions. The sensitivities of the IL-6 assay and the ELISA kit were 1 and 10 pg/ml, respectively.
###end p 41
###begin title 42
Tissue section and histology.
###end title 42
###begin p 43
###xml 299 320 295 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Halpern et al. (2003)</xref>
Tissue sections of 4 microm were cut and stained with hematoxylin/eosin using standard techniques. After staining, the codes on the bowel sections were blinded and tissue damage was quantified with four neutral observers using the necrotizing enterocolitis scoring system published and validated by Halpern et al. (2003). The mean value of their estimations was used.
###end p 43
###begin title 44
Immunohistochemistry (IHC).
###end title 44
###begin p 45
###xml 97 124 93 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Trowbridge and Thomas, 1994</xref>
###xml 132 152 128 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Haniffa et al., 2007</xref>
###xml 164 187 160 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Pinkus and Pinkus, 1991</xref>
###xml 357 385 349 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">van den Berg and Kraal, 2005</xref>
###xml 400 406 <span type="species:ncbi:9986">rabbit</span>
###xml 410 415 <span type="species:ncbi:9823">swine</span>
4-microm liver sections were deparaffinized for antigen retrieval followed by rehydration. CD45 (Trowbridge and Thomas, 1994), CD3 (Haniffa et al., 2007), and MPO (Pinkus and Pinkus, 1991) IHC used target retrieval solution (Dako) or proteinase K treatment (10 microg/ml; Promega) in proteinase K buffer (100 mM Tris-HCl, pH 8.0, and 50 mM EDTA; for F4/80; van den Berg and Kraal, 2005), blocking in rabbit or swine serum (Dako), peroxidase blocking buffer (Dako), and incubation with anti-CD45 (BD), anti-CD3 (Abcam), anti-MPO (Dako), and anti-F4/80 (AbD Serotec) antibodies. Biotin-conjugated IgGs (Dako), the Vectastain ABC kit (Vector Laboratories), and AEC (Dako) were used for visualization. The slides were counterstained with hematoxylin solution (Sigma-Aldrich). CD45-, CD3-, MPO-, and F4/80-positive cells were counted in five random 40x fields in a double-blinded fashion. Negative controls were made by substituting buffer for primary antibody.
###end p 45
###begin title 46
Real-time PCR.
###end title 46
###begin p 47
###xml 447 455 447 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;Ct</sup>
RNA samples were reverse transcribed using oligo (dT) primers and MMLV reverse transcription. Primers were designed with Primer Express (Applied Biosystems) and purchased from Biolegio. Quantitative PCR was performed using the LightCycler 480 system (Applied Biosystems) for 10 ng of complementary DNA with SYBR Green Master mix. Genes were normalized to two housekeeping genes, GAPDH and actin. The relative messenger RNA level was expressed as 2-DeltaCt (DeltaCt, relative cycle threshold compared with GAPDH and actin).
###end p 47
###begin title 48
Quantification of apoptosis in tissues.
###end title 48
###begin p 49
###xml 348 352 342 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLUS</sup>
###xml 842 843 836 837 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Liver and small intestine homogenates were centrifuged for 30 min at 13,000 rpm and supernatant was stored at 4degreesC. Apoptosis was quantified by immunochemical determination of histone-complexed DNA fragments in a microtiter plate and by measuring caspase 3 and 7 activity. DNA fragmentation was measured by using the Cell Death Detection ELISAPLUS (Roche). In brief, plates coated with streptavidin were incubated with homogenates, anti-histone-biotin, and anti-DNA-POD. Detection was performed with anti-DNA-HRP and substrate. Livers and small intestines of untreated animals were used as negative control. To detect caspase 3 and 7 activity in livers and small intestines, we used the Caspase-Glo 3/7 Assay (Promega) with a slight modification. This modified procedure used a hypotonic extraction buffer (25 mM Hepes, pH 7.5, 5 mM MgCl2, 1 mM EGTA, and 1 microg/ml each of PMSF, leupeptin, and aprotinin) during dounce homogenization of livers and small intestines. After homogenization, the extracts were cleared by two centrifugations at 13,000 rpm for 30 min at 4degreesC. Protein concentrations in the cleared extracts were adjusted to 1 mg/ml before storage at -20degreesC. To perform the caspase assays, we mixed an equal volume (10 microg/ml) of diluted extract with the appropriate Caspase-Glo reagent in 96-well white-walled plates.
###end p 49
###begin title 50
Statistical analysis.
###end title 50
###begin p 51
###xml 139 140 139 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 191 192 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Survival curves (Kaplan-Meyer plots) were compared using a log-rank test. Final mortality rates (deaths per total) were compared with a chi2 test. Means +/- SD were compared with a Student's t test. *, **, and *** represent 0.01 </= P </= 0.05, 0.001 </= P </= 0.01, and P </= 0.001, respectively.
###end p 51
###begin p 52
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
We thank Dr. D. Bonaparte (Gulbenkian Institute of Science, Oeiras, Portugal) for generously providing the IFNAR-1-/- mice. We thank W. Burm for technical assistance and Dr. A. Bredan for editing the manuscript.
###end p 52
###begin p 53
The work was supported by FWO Vlaanderen, Belgium, and the Interuniversity Attraction Poles, Belgium. L. Huys and L. Dejager are research assistants of the FWO-Vlaanderen, Belgium. F. Van Hauwermeiren was supported by a grant from Ghent University.
###end p 53
###begin p 54
The authors have no conflicting financial interests.
###end p 54
###begin article-title 55
Tumor necrosis factors: developments during the last decade.
###end article-title 55
###begin article-title 56
IFN-lambda: novel antiviral cytokines.
###end article-title 56
###begin article-title 57
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 54 60 <span type="species:ncbi:10090">murine</span>
###xml 96 102 <span type="species:ncbi:10090">murine</span>
###xml 129 135 <span type="species:ncbi:10090">murine</span>
In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma.
###end article-title 57
###begin article-title 58
Protection against TNF-induced lethal shock by soluble guanylate cyclase inhibition requires functional inducible nitric oxide synthase.
###end article-title 58
###begin article-title 59
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.
###end article-title 59
###begin article-title 60
Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury.
###end article-title 60
###begin article-title 61
Regional treatment of metastasis: role of regional perfusion. State of the art isolated limb perfusion for limb salvage.
###end article-title 61
###begin article-title 62
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Recombinant IL-1 receptor antagonist protects against TNF-induced lethality in mice.
###end article-title 62
###begin article-title 63
Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity.
###end article-title 63
###begin article-title 64
Hepatic inflammatory mediators contribute to intestinal damage in necrotizing enterocolitis.
###end article-title 64
###begin article-title 65
###xml 6 11 <span type="species:ncbi:9606">human</span>
Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells.
###end article-title 65
###begin article-title 66
ConTra: a promoter alignment analysis tool for identification of transcription factor binding sites across species.
###end article-title 66
###begin article-title 67
Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock.
###end article-title 67
###begin article-title 68
On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.
###end article-title 68
###begin article-title 69
IFN-alpha induces barrier destabilization and apoptosis in renal proximal tubular epithelium.
###end article-title 69
###begin article-title 70
Regulation of apoptosis by type III interferons.
###end article-title 70
###begin article-title 71
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Response of interleukin-6-deficient mice to tumor necrosis factor-induced metabolic changes and lethality.
###end article-title 71
###begin article-title 72
Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein.
###end article-title 72
###begin article-title 73
Interferon: cellular executioner or white knight?
###end article-title 73
###begin article-title 74
Should we inhibit type I interferons in sepsis?
###end article-title 74
###begin article-title 75
Functional role of type I and type II interferons in antiviral defense.
###end article-title 75
###begin article-title 76
###xml 36 40 <span type="species:ncbi:10090">mice</span>
TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor 1 and does not require p53.
###end article-title 76
###begin article-title 77
Myeloperoxidase: a specific marker for myeloid cells in paraffin sections.
###end article-title 77
###begin article-title 78
###xml 38 57 38 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia muridarum</italic>
###xml 38 57 <span type="species:ncbi:83560">Chlamydia muridarum</span>
Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages.
###end article-title 78
###begin article-title 79
IL-17 produced by Paneth cells drives TNF-induced shock.
###end article-title 79
###begin article-title 80
###xml 47 52 <span type="species:ncbi:9606">human</span>
Shock and tissue injury induced by recombinant human cachectin.
###end article-title 80
###begin article-title 81
CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development.
###end article-title 81
###begin article-title 82
The receptor of the type I interferon family.
###end article-title 82
###begin article-title 83
A function for the macrophage F4/80 molecule in tolerance induction.
###end article-title 83
###begin article-title 84
Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.
###end article-title 84
###begin article-title 85
TNF in autoimmune diseases, graft-versus-host reactions, and pulmonary fibrosis.
###end article-title 85
###begin article-title 86
Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy.
###end article-title 86
###begin article-title 87
TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes.
###end article-title 87
###begin p 88
Abbreviations used: IFNAR-1, IFN-alpha receptor 1; IHC, immunohistochemistry; iNOS, inducible nitric oxide synthase; ISRE, IFN-stimulated response element; SIRS, systemic inflammatory response syndrome; TSI, tumor size index; WBC, white blood cell.
###end p 88

